⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515382 | 0.86 | — | — | |
| SCHEMBL22068835 | 0.84 | KDM4E (0.36) | — | |
| SCHEMBL246647 | 0.83 | CYP2D6 (0.38) | — | |
| SCHEMBL17424836 | 0.79 | TSHR (0.43) | — | |
| SCHEMBL18986133 | 0.77 | KDM4E (0.33) | — | |
| SCHEMBL9818798 | 0.77 | PIK3CD (0.46) | — | |
| SCHEMBL17187362 | 0.77 | KDM4E (0.36) | — | |
| SCHEMBL11121197 | 0.77 | ALDH1A1 (0.43) | — | |
| SCHEMBL10144705 | 0.76 | — | — | |
| SCHEMBL580377 | 0.76 | INMT (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225450-B2 | Processes for preparing calixarenes | SI GROUP, INC. (US) | 2022-01-18 | — | — | US | claimed |
| US-20210047253-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2021-02-18 | — | — | US | claimed |
| US-10781154-B2 | Processes for preparing calixarenes | SI GROUP, INC. (US) | 2020-09-22 | — | — | US | claimed |
| US-10640641-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2020-05-05 | — | — | US | claimed |
| US-20200062953-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2020-02-27 | — | — | US | claimed |
| US-20190248721-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2019-08-15 | — | — | US | claimed |
| US-10336863-B2 | Curable composition having a special catalyst/softner system | HENKEL AG & CO. KGAA (DE) | 2019-07-02 | — | — | US | claimed |
| US-20180237635-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2018-08-23 | — | — | US | claimed |
| US-9976028-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2018-05-22 | — | — | US | claimed |
| WO-2016137881-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES (US) | 2016-09-01 | — | — | WO | claimed |
| US-20160244606-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2016-08-25 | — | — | US | claimed |
| US-8435364-B2 | Hypergolic liquid or gel fuel mixtures | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2013-05-07 | — | — | US | claimed |
| US-20110272071-A1 | Hypergolic Liquid Or Gel Fuel Mixtures | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2011-11-10 | — | — | US | claimed |
| US-8013080-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-09-06 | — | — | US | claimed |
| US-20080127551-A1 | Hypergolic Liquid Or Gel Fuel Mixtures | UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY OF THE U.S. ARMY (US) | 2008-06-05 | — | — | US | claimed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20070021472-A1 | N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility | MILLENNIUM PHARMACEUTICALS, INC. | 2007-01-25 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |